XRCC1 and ERCC1 variants modify malignant mesothelioma risk: A case–control study
- 1 March 2011
- journal article
- research article
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 708 (1-2) , 11-20
Abstract
No abstract availableKeywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro
This publication has 57 references indexed in Scilit:
- Polymorphisms in hOGG1 and XRCC1 and Risk of Prostate Cancer: Effects Modified by Plasma AntioxidantsUrology, 2010
- Prognostic Significance of X-ray Cross-complementing Group 1 T-77C Polymorphism in Resected Non-small Cell Lung CancerJapanese Journal of Clinical Oncology, 2008
- Survival of pleural malignant mesothelioma in Italy: A population‐based studyInternational Journal of Cancer, 2008
- Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesotheliomaCarcinogenesis, 2008
- A haplotype of polymorphisms in ASE-1, RAI and ERCC1and the effects of tobacco smoking and alcohol consumption on risk of colorectal cancer: a danish prospective case-cohort studyBMC Cancer, 2008
- Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian registerEuropean Journal of Cancer, 2007
- Modeling Mesothelioma Risk Associated with Environmental Asbestos ExposureEnvironmental Health Perspectives, 2007
- TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesisProceedings of the National Academy of Sciences, 2006
- SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism lociCell Research, 2005
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004